These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 10648394

  • 1. Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression.
    MacVittie TJ, Farese AM, Smith WG, Baum CM, Burton E, McKearn JP.
    Blood; 2000 Feb 01; 95(3):837-45. PubMed ID: 10648394
    [Abstract] [Full Text] [Related]

  • 2. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
    Farese AM, Casey DB, Smith WG, Vigneulle RM, McKearn JP, MacVittie TJ.
    Stem Cells; 2001 Feb 01; 19(6):522-33. PubMed ID: 11713344
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor.
    MacVittie TJ, Farese AM, Herodin F, Grab LB, Baum CM, McKearn JP.
    Blood; 1996 May 15; 87(10):4129-35. PubMed ID: 8639770
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Promegapoietin-1a, an engineered chimeric IL-3 and Mpl-L receptor agonist, stimulates hematopoietic recovery in conventional and abbreviated schedules following radiation-induced myelosuppression in nonhuman primates.
    Farese AM, Smith WG, Giri JG, Siegel N, McKearn JP, MacVittie TJ.
    Stem Cells; 2001 May 15; 19(4):329-38. PubMed ID: 11463953
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The combined administration of daniplestim and Mpl ligand augments the hematopoietic reconstitution observed with single cytokine administration in a nonhuman primate model of myelosuppression.
    Farese AM, MacVittie TJ, Lind LB, Smith WG, McKearn JP.
    Stem Cells; 1998 May 15; 16 Suppl 2():143-54. PubMed ID: 11012186
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A single dose of pegylated leridistim significantly improves neutrophil recovery in sublethally irradiated rhesus macaques.
    Farese AM, Casey DB, Vigneulle RM, Siegel NR, Finn RF, Klover JA, Smith WG, McKearn JP, MacVittie TJ.
    Stem Cells; 2001 May 15; 19(6):514-21. PubMed ID: 11713343
    [Abstract] [Full Text] [Related]

  • 11. Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice.
    Shibuya K, Akahori H, Takahashi K, Tahara E, Kato T, Miyazaki H.
    Blood; 1998 Jan 01; 91(1):37-45. PubMed ID: 9414267
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells.
    Neelis KJ, Dubbelman YD, Qingliang L, Thomas GR, Eaton DL, Wagemaker G.
    Exp Hematol; 1997 Sep 01; 25(10):1084-93. PubMed ID: 9293906
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic efficacy of recombinant interleukin-6 (IL-6) alone and combined with recombinant human IL-3 in a nonhuman primate model of high-dose, sublethal radiation-induced marrow aplasia.
    MacVittie TJ, Farese AM, Patchen ML, Myers LA.
    Blood; 1994 Oct 15; 84(8):2515-22. PubMed ID: 7919369
    [Abstract] [Full Text] [Related]

  • 14. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia.
    Farese AM, Hunt P, Grab LB, MacVittie TJ.
    J Clin Invest; 1996 May 01; 97(9):2145-51. PubMed ID: 8621805
    [Abstract] [Full Text] [Related]

  • 15. Lack of efficacy of thrombopoietin and granulocyte colony-stimulating factor after high dose total-body irradiation and autologous stem cell or bone marrow transplantation in rhesus monkeys.
    Neelis KJ, Dubbelman YD, Wognum AW, Thomas GR, Eaton DL, Egeland T, Wagemaker G.
    Exp Hematol; 1997 Sep 01; 25(10):1094-103. PubMed ID: 9293907
    [Abstract] [Full Text] [Related]

  • 16. 5-androstenediol stimulates multilineage hematopoiesis in rhesus monkeys with radiation-induced myelosuppression.
    Stickney DR, Dowding C, Garsd A, Ahlem C, Whitnall M, McKeon M, Reading C, Frincke J.
    Int Immunopharmacol; 2006 Nov 01; 6(11):1706-13. PubMed ID: 16979125
    [Abstract] [Full Text] [Related]

  • 17. Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia.
    Farese AM, Williams DE, Seiler FR, MacVittie TJ.
    Blood; 1993 Nov 15; 82(10):3012-8. PubMed ID: 8219192
    [Abstract] [Full Text] [Related]

  • 18. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.
    Harker LA, Marzec UM, Kelly AB, Cheung E, Tomer A, Nichol JL, Hanson SR, Stead RB.
    Blood; 1997 Jan 01; 89(1):155-65. PubMed ID: 8978288
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of Neulasta or Neupogen on H-ARS and GI-ARS Mortality and Hematopoietic Recovery in Nonhuman Primates After 10-Gy Irradiation With 2.5% Bone Marrow Sparing.
    Farese AM, Bennett AW, Gibbs AM, Hankey KG, Prado K, Jackson W, MacVittie TJ.
    Health Phys; 2019 Mar 01; 116(3):339-353. PubMed ID: 30281533
    [Abstract] [Full Text] [Related]

  • 20. Hematopoietic recovery following autologous bone marrow transplantation in a nonhuman primate: effect of variation in treatment schedule with PEG-rHuMGDF.
    Farese AM, MacVittie TJ, Roskos L, Stead RB.
    Stem Cells; 2003 Mar 01; 21(1):79-89. PubMed ID: 12529554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.